Beton Dickinson (BDX) is a super safe stock. The company’s been in business since the 1800s. But the stock is a slow grower.

Becton Dickenson (BDX) could be what the doctor ordered, as this stock has been going up while other stocks have been falling.

Decon Dickinson (BDX) stock fell after the outgoing CFO lowered 2022 guidance. But this sets up the new CFO to overdeliver.

With a Beta of 0.77, Becton Dickinson (BDX) is a great stock for conservative investors in search of double-digit returns.

Becton, Dickinson (BDX) is seeing stronger demand for its hospital supplies while COVID-19 diagnostic sales surge.

Medical device company Becton Dickinson (BDX) sees revenue growth accelerating from 4% last qtr to 27% this qtr.

Becton Dickenson (BDX) should have a rebound in sales in 2021, and could also get a boost from COVID-19 products.

Medical supply company Becton, Dickenson (BDX) is suffering as elective procedures are down significantly.

Medical supply company Becton Dickenson (BDX) has delivered positive returns to its stock investors 8 straight years,

Medical supply company Becton Dickenson (BDX) expects profit growth to accelerate in the 2nd half of 2019.

Becton, Dickenson (BDX) is a dependable Healthcare company that traces its roots back more than 100 years.

Becton, Dickinson (BDX) doesn’t get appreciated enough because smarty-pants investors instead choose to do stupid things with their money.

If you want to own stocks – yet keep your money safe – Becton Dickenson (BDX) might be for you. BDX has grown 13% a year the past decade, and upped the dividend 46 years.

Looking for a healthcare stock to add to your portfolio? Take a look at Becton Dickenson (BDX) which has provided pharmaceutical products for more than 100 years.

Becton, Dickinson (BD) has completed its merger with C.R. Bard, and the new company is seeing good growth in China and abroad.

Becton Dickenson (BDX) has been in a groove the past five years, and even through a stock market correction the stock keeps doin what it’s been doin.

Becton, Dickinson (BDX) closed out 2017 with profit growth of 15%. Now with the merger of CR Bard, the new company will be a powerhouse in the field of hospital supplies.

The merger between Becton Dickinson (BDX) and C.R. Bard is expected to close in the 4th qtr of this year, and BDX stock is rallying ahead of the big event.

Becton, Dickinson (BDX) is acquiring C.R. Bard, which is a great move. Both companies have steady business providing medical products to hospitals.

Becton Dickinson (BDX) has a strategy for sustainable growth that could help the company continue on its path of 10% annual profit growth.

Becton, Dickinson (BDX) has been growing profits rapidly due to its acquisition of CareFusion, but that was more than a year ago and now profit growth has normalized.

Becton, Dickinson (BDX) makes medical products that sell all around the world. It offers investors a Healthcare stock that’s not under attack from a likely Clinton win.

Medical supply company Becton Dickenson (BDX) continues to be a hot stock as Carefusion is boosting both sales and profits.

A recent acquisition has kicked growth up a notch for Becton Dickinson (BDX) and that gives the stock the ability to break out.

Becton Dickenson (BDX) has found the fountain of youth, and now profits are growing at twice the rate they used to.

Bexton, Dickinson (BDX) is a rare find, a conservative stock that’s experiencing 20% profit growth and sells for less than 20x earnings.